← Torna allo Screener

Agios Pharmaceuticals

AGIO Small Cap

Healthcare · Biotechnology

Aggiornato: May 2, 2026, 22:05 UTC

24,02 €
+0.57% oggi
52W: 18,97 € – 39,24 €
52W Low: 18,97 € Posizione: 24.9% 52W High: 39,24 €

Metriche Chiave

P/E Ratio
Rapporto P/E
Forward P/E
P/E Forward
P/S Ratio
25.36x
Prezzo/Vendite
EV/EBITDA
Valore Impresa/EBITDA
Rendimento Dividendi
Rendimento annuale da dividendi
Cap. di Mercato
1,4 Mrd. €
Capitalizzazione di Mercato
Crescita Ricavi
137.7%
Crescita Ricavi Anno su Anno
Margine di Profitto
Margine Netto
ROE
-32.81%
Return on Equity
Beta
0.79
Sensibilità al mercato
Interesse Corto
12.17%
% del flottante in vendita allo scoperto
Volume Medio
1,061,437
Volume Medio Giornaliero

Analisi della Valutazione

Segnale
N/A
vs. P/E medio S&P 500 (24,7x)
Consenso degli Analisti
Comprare
8 analisti
Prezzo Obiettivo Medio
35,08 €
+46.04% potenziale
Range Obiettivo
23,88 € – 51,18 €

Informazioni sull'Azienda

Settore: Healthcare Industria: Biotechnology Paese: United States Dipendenti: 539 Borsa: NMS

Agios Pharmaceuticals Stock at a Glance

Agios Pharmaceuticals (AGIO) is currently trading at 24,02 € with a market capitalization of 1,4 Mrd. €. The 52-week range spans from 18,97 € to 39,24 €; the current price is 38.8% below the yearly high. Year-over-year revenue growth stands at +137.7%.

💰 Dividendo

Agios Pharmaceuticals currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Raccomandazioni degli Analisti

8 analysts rate Agios Pharmaceuticals (AGIO) on consensus: Comprare. The average price target is 35,08 €, implying +46.04% from the current price. Analyst price targets range from 23,88 € to 51,18 €.

Tesi di Investimento: Punti di Forza e Debolezze

Punti di Forza
  • Strong revenue growth of 137.7% YoY
  • Analyst consensus: Buy
  • Solid balance sheet with low debt (D/E 3.22)
Debolezze
  • High short interest (12.17%)
  • Negative free cash flow

Panoramica Tecnica

MM 50 Giorni
25,36 €
-5.28% vs. prezzo
MM 200 Giorni
28,34 €
-15.23% vs. prezzo
Sotto Massimo 52S
−38.8%
39,24 €
Sopra Minimo 52S
+26.6%
18,97 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profilo di Rischio

Rischio di Mercato (Beta)
0.79 · Defensive
Moves less than the overall market
Short Interest
12.17% · High
% del flottante in vendita allo scoperto
Debt-to-Equity
3.22 · Low
Debito totale / patrimonio

The data points to relatively defensive market behavior, elevated short interest (12.17%).

Dati di Trading

50-Day MA: 25,36 €
200-Day MA: 28,34 €
Volume: 1,137,388
Volume Medio: 1,061,437
Ratio Corto: 6.79
Rapporto P/B: 1.38x
Debito/Patrimonio: 3.22x
Flusso di Cassa Libero: -227.946.779 €

Where can I buy Agios Pharmaceuticals?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top